National Institute on Aging National Institutes of Health

NIA Intramural-Home NIH Clinical Trials-Home NIA Clinical Studies-Home

NIA Clinical Studies

Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

This study is currently recruiting.

This phase II trial is studying how well giving bryostatin 1 together with rituximab works in treating patients with B-cell non-Hodgkin's lymphoma or chronic lymphocytic leukemia that has not responded to previous treatment with rituximab

For More Information and to be Screened for Eligibility

PLEASE CALL: 410-350-3939 - or - Register Online

Email: NIAStudiesRecruitment@mail.nih.gov

Additional information can be found at NIH ClinicalTrials.gov -1- and -2-

Principal Investigator: William Ershler, M.D. NIA Study #: 2004-055

NIA - ASTRA Unit Advanced Studies in Translational Research on Aging

Harbor Hospital 3001 Hanover Street Baltimore, MD 21225

IRP Home     What's New     Contact Us     Accessibility     Disclaimer     Privacy     Site Search     Site Map     NIA Home

Updated: Thursday October 11, 2007